tiprankstipranks
Advertisement

TIER - ETF AI Analysis

Compare

Top Page

TIER

T. Rowe Price International Equity Research ETF (TIER)

Rating:63Neutral
Price Target:
TIER, the T. Rowe Price International Equity Research ETF, earns a solid overall rating driven largely by high-quality holdings like TSM and ASML, which benefit from strong financial performance, positive earnings sentiment, and strategic positioning in advanced technologies and AI. Additional support comes from well-established names such as AstraZeneca, HSBC, and Novartis, all showing strong fundamentals and constructive outlooks, though some holdings face valuation concerns and signs of overbought or short-term bearish momentum. The main risk factor is the fund’s meaningful exposure to a handful of large, globally focused companies where high valuations and technical caution could lead to periods of volatility.
Positive Factors
Strong Overall Performance
The ETF has delivered strong year-to-date and recent short-term returns, showing solid momentum.
Leading Semiconductor Holdings
Top positions in major chipmakers like TSMC, SK hynix, Samsung, and ASML have performed strongly and helped drive gains.
Broad International Diversification
The fund spreads its investments across many countries and sectors, reducing the impact of weakness in any single market or industry.
Negative Factors
Moderate Expense Ratio
The ETF’s fees are not especially high but are above the lowest-cost index funds, slightly reducing net returns over time.
Concentration in Financials and Technology
Significant exposure to financial and technology stocks means the fund can be more sensitive to downturns in these sectors.
Mixed Health Care Holdings
Some large health care positions, such as AstraZeneca, have shown weaker recent performance, which can weigh on the fund.

TIER vs. SPDR S&P 500 ETF (SPY)

TIER Summary

T. Rowe Price International Equity Research ETF (TIER) is an actively managed fund that invests in a wide range of companies outside the U.S., following a broad international “total market” theme rather than tracking a specific index. It holds well-known global names like TSMC, Samsung Electronics, ASML, AstraZeneca, and HSBC, across many sectors and regions, including Europe and Asia. Investors might consider TIER for global diversification and long-term growth potential guided by T. Rowe Price’s research team. A key risk is that international stock prices can rise or fall sharply with global markets and currency swings.
How much will it cost me?The T. Rowe Price International Equity Research ETF (Ticker: TIER) has an expense ratio of 0.38%, which means you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it is actively managed, leveraging T. Rowe Price's in-depth research to select stocks globally.
What would affect this ETF?The TIER ETF, with its focus on global equities outside the U.S., could benefit from economic growth in emerging markets and technological advancements, particularly given its exposure to companies like Tencent, TSMC, and Samsung. However, it may face challenges from geopolitical tensions, regulatory changes in key regions like China, and global economic slowdowns, which could impact sectors such as financials and technology. Additionally, currency fluctuations and rising interest rates could affect international investments and overall performance.

TIER Top 10 Holdings

TIER is leaning heavily on the global chip boom, with TSMC, SK hynix, Samsung, and ASML acting as the fund’s main growth engine as semiconductor names keep climbing, even if ASML has cooled a bit lately. Financial heavyweights like HSBC and Royal Bank of Canada are providing a steadier tailwind, helping smooth out volatility. On the flip side, big pharma players such as AstraZeneca and Novartis have been losing steam, modestly dragging on returns. Overall, it’s a diversified ex-U.S. mix, but with a clear tilt toward tech-driven growth overseas.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
TSMC2.57%$3.17M$2.03T73.51%
81
Outperform
SK hynix Inc.2.03%$2.51M₩10.00T>543.68%
Samsung Electronics1.54%$1.90M$1.28T292.64%
ASML Holding1.34%$1.65M$666.66B115.37%
81
Outperform
BHP Group Ltd1.09%$1.35MAU$319.90B77.76%
68
Neutral
AstraZeneca1.09%$1.34M$252.93B-0.84%
80
Outperform
HSBC Holdings1.08%$1.34M£270.96B61.29%
80
Outperform
Royal Bank Of Canada1.06%$1.30M$293.34B45.63%
75
Outperform
Roche Holding AG1.00%$1.23M$348.56B29.76%
73
Outperform
Novartis AG0.98%$1.21MCHF229.66B9.54%
80
Outperform

TIER Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
32.43
Positive
100DMA
32.01
Positive
200DMA
30.57
Positive
Market Momentum
MACD
0.11
Positive
RSI
44.80
Neutral
STOCH
47.37
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TIER, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 32.96, equal to the 50-day MA of 32.43, and equal to the 200-day MA of 30.57, indicating a neutral trend. The MACD of 0.11 indicates Positive momentum. The RSI at 44.80 is Neutral, neither overbought nor oversold. The STOCH value of 47.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TIER.

TIER Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$141.06M0.38%
63
Neutral
$792.08M0.69%
59
Neutral
$507.06M0.34%
60
Neutral
$436.50M0.55%
72
Outperform
$295.37M0.60%
61
Neutral
$162.07M0.60%
59
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TIER
T. Rowe Price International Equity Research ETF
32.50
5.70
21.27%
JDVI
John Hancock Disciplined Value International Select ETF
BRIE
MFS Blended Research International Equity ETF
OSEA
Harbor International Compounders ETF
QLTI
GMO International Quality ETF
BAIV
Brown Advisory International Value Select ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement